Indeed, tumor-reactive T lymphocytes express high levels of PD-1 following antigen encounter and effective activation.13 14 This high PD-1 expression renders them susceptible to programmed death ligands (PD-L)1/PD-L2-mediated inhibition in the tumor microenvironment (TME). This evidence concerns the gene PDCD1 and neoplasm.